Overview

DFA-02 in Patients Undergoing Colorectal Surgery

Status:
Completed

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

Summary

This is a randomized, double-blind, placebo controlled, safety, tolerability, and pharmacokinetic dose escalation Phase II study of DFA-02 in patients undergoing colorectal surgery to evaluate the safety, tolerability and pharmacokinetics of DFA-02.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Dr. Reddy's Laboratories Limited

Collaborator:

Duke Clinical Research Institute